CAMP4 THERAPEUTICS CORP (CAMP) Forecast, Price Target & Analyst Ratings

NASDAQ:CAMPUS13463J1016

Current stock price

5 USD
-0.16 (-3.1%)
At close:
5.002 USD
+0 (+0.04%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CAMP4 THERAPEUTICS CORP (CAMP).

Forecast Snapshot

Consensus Price Target

Price Target
$8.93
+ 78.50% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.21
Revenue Estimate
905.25K

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.93
Upside
+ 78.50%
From current price of $5.00 to mean target of $8.93, Based on 12 analyst forecasts
Low
$7.07
Median
$8.16
High
$12.60

Price Target Revisions

1 Month
0.00%
3 Months
2.94%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for CAMP. The average price target is 8.93 USD. This implies a price increase of 78.5% is expected in the next year compared to the current price of 5.
The average price target has been revised upward by 2.94% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

CAMP Current Analyst RatingCAMP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

CAMP Historical Analyst RatingsCAMP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
CAMP was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CAMP.
In the previous month the buy percentage consensus was at a similar level.
CAMP was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-10-02Cantor FitzgeraldInitiate Overweight
2025-09-16JP MorganDowngrade Overweight -> Neutral
2025-09-15Piper SandlerMaintains Overweight -> Overweight
2025-05-27WedbushInitiate Outperform
2024-11-05Leerink PartnersInitiate Outperform
2024-11-05William BlairInitiate Outperform
2024-11-05JP MorganInitiate Overweight
2024-11-05Piper SandlerInitiate Overweight
2024-01-11Goldman SachsMaintains Sell -> Sell
2023-10-09Goldman SachsMaintains Sell -> Sell
2023-10-06Roth MKMMaintains Buy -> Buy
2023-10-06Craig-HallumDowngrade Buy -> Hold
2023-08-29Roth MKMReiterate Buy -> Buy
2023-07-13Goldman SachsMaintains Sell -> Sell
2023-07-11Craig-HallumMaintains Buy -> Buy
2023-06-26JefferiesDowngrade Buy -> Hold
2023-05-01Goldman SachsMaintains Sell
2023-04-28Craig-HallumMaintains Buy
2023-04-18Goldman SachsMaintains Sell
2022-10-14Goldman SachsMaintains Sell
2022-08-16Craig-HallumUpgrade Hold -> Buy
2021-12-22Canaccord GenuityMaintains Buy
2021-12-22Craig-HallumDowngrade Buy -> Hold
2021-06-25Roth CapitalMaintains Buy
2021-04-23Canaccord GenuityMaintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.21
Revenue Estimate
905.25K
Revenue Q2Q
5.51%
EPS Q2Q
65.45%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
195.83%
Revenue (3 Months)
343.75%
EPS (1 Month)
20.25%
EPS (3 Months)
28.41%

Next Earnings Summary

CAMP is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.21 USD and the consensus revenue estimate is 905.25K USD.
The next earnings revenue estimate has been revised upward by 343.75% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CAMP revenue by date.CAMP revenue by date.
350K652K
86.29%
3.5M
436.81%
3.302M
-5.66%
4.723M
43.03%
18.763M
297.27%
43.064M
129.52%
82.009M
90.44%
37.321M
-54.49%
138.9M
272.18%
245.91M
77.04%
EBITDA
YoY % growth
CAMP ebitda by date.CAMP ebitda by date.
-50.32M
-14.04%
-51.3M
-1.95%
-50.87M
0.84%
-62.22M
-22.31%
-74.46M
-19.67%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CAMP ebit by date.CAMP ebit by date.
-52M
-15.55%
-53M
-1.92%
-52.51M
0.92%
-56.981M
-8.51%
-70.3M
-23.37%
-73.452M
-4.48%
-60.916M
17.07%
-46.867M
23.06%
-106.68M
-127.62%
-41.74M
60.87%
34.474M
182.59%
Operating Margin
CAMP operating margin by date.CAMP operating margin by date.
-14,857.14%-8,128.83%-1,500.29%-1,725.64%-1,488.46%-391.48%-141.45%-57.15%-285.85%-30.05%14.02%
EPS
YoY % growth
CAMP eps by date.CAMP eps by date.
1.26
1,700.00%
N/A
-591.99%
-2.65
57.25%
-0.94
64.46%
-0.86
8.21%
-0.82
5.22%
-0.63
22.82%
-0.47
26.34%
-0.82
-76.26%
0.08
109.32%
0.89
1,060.00%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.21
65.45%
-0.25
59.42%
-0.21
61.67%
-0.20
77.07%
Revenue
Q2Q % growth
905.25K
5.51%
306K
-79.56%

-100.00%

-100.00%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-12.727M
2.10%
-15.72M
-20.92%
-16.194M
-19.87%
-17.13M
-31.77%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CAMP Yearly Revenue VS EstimatesCAMP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
CAMP Yearly EPS VS EstimatesCAMP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
19.13%
EPS Next 5 Year
12.78%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
72.16%
Revenue Next 5 Year
86.07%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

CAMP4 THERAPEUTICS CORP / CAMP Forecast FAQ

What is the price target for CAMP stock?

12 analysts have analysed CAMP and the average price target is 8.93 USD. This implies a price increase of 78.5% is expected in the next year compared to the current price of 5.

When does CAMP4 THERAPEUTICS CORP (CAMP) report earnings?

CAMP4 THERAPEUTICS CORP (CAMP) will report earnings on 2026-05-11.

Can you provide the consensus estimates for CAMP4 THERAPEUTICS CORP next earnings?

The consensus EPS estimate for the next earnings of CAMP4 THERAPEUTICS CORP (CAMP) is -0.21 USD and the consensus revenue estimate is 905.25K USD.

How do analysts rate CAMP4 THERAPEUTICS CORP (CAMP)?

The consensus rating for CAMP4 THERAPEUTICS CORP (CAMP) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.